Skip to main content
Springer logoLink to Springer
. 2018 Dec 12;78(18):1911. doi: 10.1007/s40265-018-1034-z

Correction to: Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia

Hannah A Blair 1,
PMCID: PMC6294813  PMID: 31329656

Correction to: Drugs 10.1007/s40265-018-1022-3

The article Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia, written by Hannah A. Blair, was originally published Online First without open access. After publication online Jazz Pharmaceuticals, Inc., requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Jazz Pharmaceuticals, Inc. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The original article has been corrected.


Articles from Drugs are provided here courtesy of Springer

RESOURCES